Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2014, Article ID 242703, 8 pages
http://dx.doi.org/10.1155/2014/242703
Case Report

Nicardipine-Induced Acute Pulmonary Edema: A Rare but Severe Complication of Tocolysis

1Service d’Anesthésie-Réanimation, Hôpital Mère Enfant, 08 avenue Dominique Larrey, 87000 Limoges, France
2Service de Réanimation Polyvalente, CIC 0801, CHU Dupuytren, 02 avenue Martin Luther King, 87000 Limoges, France

Received 26 June 2014; Revised 4 August 2014; Accepted 5 August 2014; Published 19 August 2014

Academic Editor: Chiara Lazzeri

Copyright © 2014 Claire Serena et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Gáspár and J. Hajagos-Tóth, “Calcium channel blockers as tocolytics: principles of their actions, adverse effects and therapeutic combinations,” Pharmaceuticals, vol. 6, no. 6, pp. 689–699, 2013. View at Publisher · View at Google Scholar
  2. S. G. Oei, “Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 126, no. 2, pp. 137–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Savitz, C. A. Blackmore, and J. M. Thorp, “Epidemiologic characteristics of preterm delivery: etiologic heterogeneity,” American Journal of Obstetrics and Gynecology, vol. 164, no. 2, pp. 467–471, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. G. J. Clesham, J. Scott, C. M. Oakley et al., “β Adrenergic agonists and pulmonary oedema in preterm labour,” British Medical Journal, vol. 308, no. 6923, pp. 260–262, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Samet, F. Bayoumeu, D. Longrois, and M. C. Laxenaire, “Acute pulmonary edema associated with the use of beta2-mimetic tocolytic agents,” Annales Françaises d'Anesthésie et de Réanimation, vol. 19, pp. 35–38, 2000. View at Google Scholar
  6. V. Tsatsaris and B. Carbonne, “Tocolysis with calcium-channel-blockers,” Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol. 30, pp. 246–251, 2001. View at Google Scholar
  7. C. Vayssière, “Special management for threatened preterm delivery in multiple pregnancies,” Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol. 31, no. 5, pp. S114–S123, 2002. View at Google Scholar
  8. V. Tsatsaris, F. Goffinet, B. Carbonne, G. Abitayeh, and D. Cabrol, “Tocolysis by first intention with nifedipine,” Gynecologie Obstetrique Fertilite, vol. 33, no. 4, pp. 263–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Bekkari, J. Lucas, T. Beillat, A. Chéret, and M. Dreyfus, “Tocolysis with nifedipine: its use in current practice,” Gynécologie Obstétrique & Fertilité, vol. 33, no. 7-8, pp. 483–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Tsatsaris, D. Papatsonis, F. Goffinet, G. Dekker, and B. Carbonne, “Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis,” Obstetrics and Gynecology, vol. 97, no. 5, pp. 840–847, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. de La Chapelle, S. Benoit, M. Bouregba, M. Durand-Reville, and M. Raucoules-Aimé, “The treatment of severe pulmonary edema induced by beta adrenergic agonist tocolytic therapy with continuous positive airway pressure delivered by face mask,” Anesthesia & Analgesia, vol. 94, no. 6, pp. 1593–1594, 2002. View at Google Scholar · View at Scopus
  12. R. J. Pisani and E. C. Rosenow III, “Pulmonary edema associated with tocolytic therapy,” Annals of Internal Medicine, vol. 110, no. 9, pp. 714–718, 1989. View at Google Scholar · View at Scopus
  13. J. E. Ferguson II, D. C. Dyson, T. Schutz, and D. K. Stevenson, “A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome,” American Journal of Obstetrics and Gynecology, vol. 163, no. 1, pp. 105–111, 1990. View at Publisher · View at Google Scholar · View at Scopus
  14. W. R. Meyer, H. W. Randall, and W. L. Graves, “Nifedipine versus ritodrine for suppressing preterm labor,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 35, no. 6, pp. 649–653, 1990. View at Google Scholar · View at Scopus
  15. L. A. Bracero, E. Leikin, N. Kirshenbaum, and N. Tejani, “Comparison of nifedipine and ritodrine for the treatment of preterm labor,” The American Journal of Perinatology, vol. 8, no. 6, pp. 365–369, 1991. View at Google Scholar · View at Scopus
  16. M. Kupferminc, J. B. Lessing, Y. Yaron, and M. R. Peyser, “Nifedipine versus ritodrine for suppression of preterm labour,” British Journal of Obstetrics and Gynaecology, vol. 100, no. 12, pp. 1090–1094, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. C. S. Smith and M. B. Woodland, “Clinical comparison of oral nifedipine and subcutaneous terbutaline for initial tocolysis,” The American Journal of Perinatology, vol. 10, no. 4, pp. 280–284, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. D. N. M. Papatsonis, H. P. van Geijn, H. J. Adèr, F. M. Lange, O. P. Bleker, and G. A. Dekker, “Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial,” Obstetrics and Gynecology, vol. 90, no. 2, pp. 230–234, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. García-Velasco and A. González González, “A prospective, randomized trial of nifedipine vs. ritodrine in threatened preterm labor,” Journal of the International Federation of Gynaecology and Obstetrics International Federation of Gynaecology and Obstetrics, vol. 61, pp. 239–244, 1998. View at Google Scholar
  20. C. A. Koks, H. A. Brölmann, M. J. de Kleine, and P. A. Manger, “A randomized comparison of nifedipine and ritodrine for suppression of preterm labor,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 77, pp. 171–176, 1998. View at Google Scholar
  21. S. G. Oei, B. W. J. Mol, M. J. K. De Kleine, and H. A. M. Brölmann, “Nifedipine versus ritodrine for suppression of preterm labor: a meta-analysis,” Acta Obstetricia et Gynecologica Scandinavica, vol. 78, no. 9, pp. 783–788, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. King, V. J. Flenady, D. N. Papatsonis, G. A. Dekker, and B. Carbonne, “Calcium channel blockers for inhibiting preterm labour,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD002255, 2003. View at Google Scholar · View at Scopus
  23. A. Conde-Agudelo, R. Romero, and J. P. Kusanovic, “Nifedipine in the management of preterm labor: a systematic review and metaanalysis,” American Journal of Obstetrics and Gynecology, vol. 204, no. 2, pp. 134.e1–134.e20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. D. M. Haas, D. M. Caldwell, P. Kirkpatrick, J. J. McIntosh, and N. J. Welton, “Tocolytic therapy for preterm delivery: systematic review and network meta-analysis,” The British Medical Journal, vol. 345, no. 7879, Article ID e6226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Carbonne and V. Tsatsaris, “Which tocolytic drugs in case of preterm labor?” Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol. 31, pp. 5S96–5S104, 2002. View at Google Scholar
  26. D. Jannet, A. Abankwa, B. Guyard, B. Carbonne, L. Marpeau, and J. Milliez, “Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomized study,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 73, no. 1, pp. 11–16, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Trabelsi, H. H. Taib, H. Amouri et al., “Nicardipine versus salbutamol in the treatment of premature labor: comparison of their efficacy and side effects,” Tunisie Medicale, vol. 86, no. 1, pp. 43–48, 2008. View at Google Scholar · View at Scopus
  28. P. Rozenberg, “Licensed or non-licensed tocolysis?” Gynécologie, Obstétrique & Fertilité, vol. 33, no. 4, p. 259, 2005 (French). View at Google Scholar
  29. A. C. Sciscione, T. Ivester, M. Largoza, J. Manley, P. Shlossman, and G. H. C. Colmorgen, “Acute pulmonary edema in pregnancy,” Obstetrics and Gynecology, vol. 101, no. 3, pp. 511–515, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Akerman, A. Mignon, V. Tsatsaris, S. Jacqmin, D. Cabrol, and F. Goffinet, “Pulmonary edema during calcium-channel blockers therapy: Role of predisposing or pharmacologic factors?” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 36, no. 4, pp. 389–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Vaast, S. Dubreucq-Fossaert, V. Houfflin-Debarge et al., “Acute pulmonary oedema during nicardipine therapy for premature labour; report of five cases,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 113, no. 1, pp. 98–99, 2004. View at Google Scholar
  32. C. Chapuis, E. Menthonnex, G. Debaty et al., “Acute pulmonary edema during nicardipine and salbutamol therapy for preterm labor in twin pregnancy,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 34, no. 5, pp. 493–496, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-J. Philippe, A. Le Trong, H. Pigeau et al., “Acute pulmonary edema occurred during tocolytic treatment using nicardipine in a twin pregnancy. Report of three cases,” Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol. 38, no. 1, pp. 89–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Janower, B. Carbonne, V. Lejeune, D. Apfelbaum, F. Boccara, and A. Cohen, “Acute pulmonary edema during preterm labor: Role of nicardipine tocolysis (three cases),” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 34, no. 8, pp. 807–812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. G. Oei, S. K. Oei, and H. A. Brölmann, “Myocardial infarction during nifedipine therapy for preterm labor,” The New England Journal of Medicine, vol. 340, no. 2, p. 154, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Mueller, A. Scholer, K. Laule-Kilian et al., “Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea,” The New England Journal of Medicine, vol. 350, no. 7, pp. 647–654, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Torbicki, A. Perrier, S. Konstantinides et al., “Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC),” European Heart Journal, vol. 29, no. 18, pp. 2276–2315, 2008. View at Publisher · View at Google Scholar
  38. O. M. Abbas, A. H. Nassar, N. A. Kanj, and I. M. Usta, “Acute pulmonary edema during tocolytic therapy with nifedipine,” The American Journal of Obstetrics and Gynecology, vol. 195, no. 4, pp. e3–e4, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. S. Kutuk, M. T. Ozgun, S. Uludag, M. Dolanbay, and A. Yildirim, “Acute pulmonary failure due to pulmonary edema during tocolytic therapy with nifedipine,” Archives of Gynecology and Obstetrics, vol. 288, no. 4, pp. 953–954, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. L. H. M. Seinen, S. O. Simons, M. A. van der Drift, J. van Dillen, F. P. H. A. Vandenbussche, and F. K. Lotgering, “Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation,” Nederlands Tijdschrift voor Geneeskunde, vol. 157, no. 1, Article ID A5316, 2013. View at Google Scholar · View at Scopus
  41. S. Hunter and S. C. Robson, “Adaptation of the maternal heart in pregnancy,” British Heart Journal, vol. 68, no. 6, pp. 540–543, 1992. View at Publisher · View at Google Scholar · View at Scopus
  42. D. R. Abernethy and J. B. Schwartz, “Calcium-antagonist drugs,” The New England Journal of Medicine, vol. 341, no. 19, pp. 1447–1457, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. D. J. Triggle, “Calcium, calcium channels, and calcium channel antagonists,” Canadian Journal of Physiology and Pharmacology, vol. 68, no. 11, pp. 1474–1481, 1990. View at Google Scholar · View at Scopus
  44. L. B. Ware and M. A. Matthay, “Acute pulmonary edema,” The New England Journal of Medicine, vol. 353, no. 26, pp. 2788–2796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Jessup and S. Brozena, “Medical progress: heart failure,” The New England Journal of Medicine, vol. 348, no. 20, pp. 2007–2018, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Perbet, J. Constantin, F. Bolandard et al., “Non-invasive ventilation for pulmonary edema associated with tocolytic agents during labour for a twin pregnancy,” Canadian Journal of Anesthesia, vol. 55, no. 11, pp. 769–773, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Fujita, K. Tachibana, M. Takeuchi, and K. Kinouchi, “Successful perioperative use of noninvasive positive pressure ventilation in a pregnant woman with acute pulmonary edema,” Masui, vol. 63, pp. 557–560, 2014. View at Google Scholar
  48. Royal College of Obstetricians and Gynaecologists, Tocolytic Drugs for the Women in Preterm Labour. Clinical Guideline No. 1(B), 2002.
  49. L. Bal, S. Thierry, E. Brocas, M. Adam, A. van de Louw, and A. Tenaillon, “Pulmonary edema induced by calcium-channel blockade for tocolysis,” Anesthesia and Analgesia, vol. 99, no. 3, pp. 910–911, 2004. View at Publisher · View at Google Scholar · View at Scopus